Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate efficacy and safety of etanercept 100 mg (50 mg
twice a week) compared with 50 mg once a week in adult subjects with ankylosing spondylitis
(AS) and previous failure to usual practice therapies in Spain.